×
Home Current Archive Editorial board
News Contact
Review paper

Does the new vascular management of acute limb ischemia have effective results with lower treatment costs

By
Haris Vukas Orcid logo ,
Haris Vukas
Contact Haris Vukas

Department of Surgery, Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina

Samra Kadić-Vukas ,
Samra Kadić-Vukas

Department of Neurology, Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina

Senad Dervišević ,
Senad Dervišević

Department of Surgery, Cantonal Hospital Zenica,, Zenica, Bosnia and Herzegovina

Adis Salihbegović ,
Adis Salihbegović

Institute of Forensic Medicine and Forensic Toxicology, School of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina

Haris Vranić ,
Haris Vranić

Clinic of Cardio-Vascular Surgery, Clinical Centre of the University of Sarajevo, Sarajevo, Bosnia and Herzegovina

Muhamed Djedović ,
Muhamed Djedović

Clinic of Cardio-Vascular Surgery, Clinical Centre of the University of Sarajevo, Sarajevo, Bosnia and Herzegovina

Amel Hadžimehmedagić ,
Amel Hadžimehmedagić

Clinic of Cardio-Vascular Surgery, Clinical Centre of the University of Sarajevo, Sarajevo, Bosnia and Herzegovina

Dragan Totić
Dragan Totić

Clinic of Cardio-Vascular Surgery, Clinical Centre of the University of Sarajevo, Sarajevo, Bosnia and Herzegovina

Abstract

Aim
To compare hospital costs of acute limb ischemia treatment in two periods of time and to show evidence of long-term repercussions on reducing costs during successful treatment.
Methods
Retrospective analysis of data obtained from 100 patients' medical history in the period 2000-2016 at the Clinic of Vascular Surgery Sarajevo: group A-60 patients with acute limb ischemia in the period 2005-2016 and group B-40 patients with acute limb ischemia (ALI) in the period 2000-2005. From 2000 to 2005 conservative treatment method was used, invasive diagnostic and surgical procedures were often delayed for a shorter or longer period of time. During the period from 2005 to 2016, the management model and safe practice included emergency diagnostic procedures, colour-Doppler, arteriography, emergency surgery (embolectomy by Fogharty and if necessary, vascular bypass).
Results
Better health service for the patients with acute limb ischemia was offered in the period 2005-2016, which relied on proven medical treatment trends. The largest share of the total costs of each patient included costs of hospital bed with significant difference between the period 2005-2016 and 2000-2005, mean of 1398.71 KM and 2480.45KM, respectively (p <0.0001), indicating rationalization of time that patients spend at the Vascular Clinic.
Conclusion
This trend of money/fund savings is an example of good practice, effectiveness and efficiency in the treatment of ALI and as such was used in patients with other vascular diseases.

References

1.
Health 2020: the European policy for health and well-being. World Health Organization for Europe; 24AD.
2.
Supporting public health in Europe. European Union; 24AD.
3.
Syed S, Leatherman S, Mensah-Abrampah N, Neilson M, Kelley E. Improving the quality of health care across the health system. Bull World Health Organ. 2018. p. 799.
4.
International Organization for Standardization. 24AD.
5.
Management of quality of care: Standards. World Health Organization; 24AD.
6.
Aune S, Trippesrad A. Operative mortality and long term survival of patients operated on for acute lower limb ischemia. Eur J Vasc Surg. 1998. p. 143–6.
7.
Haimovici H. Peripheral arterial embolism: a study of 330 unselected cases of embolism of the extremities. Angiology. 1950. p. 2–45.
8.
Abbott W, Maloney R, Mccabe C, Lee C, Wirthlin L. Arterial embolism: a 44 year perspective. Am J Surg. 1982. p. 460–4.
9.
Haridas A, Bhat B. Peripheral vascular thrombo-embolism and the role of various fogarty arterial thrombo-embolectomy catheters: a comparative prospective study and its result. J Vas Dis Treat. 2018. p. 3–6.
10.
Mohamed A, Tawil A, Salihi A, Mattos M, M. Left atrial myxoma embolization presenting as Acute limb ischemia: an unusual presentation. Cureus. 2018. p. 2764.
11.
If we look at the overall picture of improving management models, safe practices economic rationalizations, we concluded that in the period of 2005 to 2016 better health service were offered to the patients relying on medically proven trends of ALI treatment. While we should not forget responsibility towards the entire society which provides funding, improving medical treatment and lifelong education of medical staff is crucial for quality health care. FUNDING No specific funding was received for this study TRANSPARANCY DECLARATION Competing interest: None to declare.
12.
Wu M, Lee L, Lin C, Chen T, Tsai Y, Chen Y, et al. Atrial myxoma inducing acute stroke and mimicking ST-elevation myocardial infarction: a case report. Biomedical Research. 2018. p. 2773–5.
13.
Mirijello A, Errico D, Curci M, Spatuzza S, Graziano P, D, et al. Paradoxical embolism with thrombus stuck in a patent foramen ovale: a review of treatment strategies. Eur Rev Med Pharmacol Sci. 2018. p. 8885–90.
14.
Tuzovic M, Herrmann J, Iliescu C, Marmagkiolis K, Ziaeian B, Yang E. Arterial thrombosis in patients with cancer. Curr Treat Options Cardio Med. 2018. p. 40.
15.
Vukas H, Kadić-Vukas S, Salihbegović A, Djedović M, Totić D, Vranić H, et al. Costeffectiveness analysis of treatment acute deep vein thrombosis in Clinic of Vascular Surgery Sarajevo. Open Access Maced J Med Sci. 2017. p. 681–5.
16.
Singh S, Evans L, Datta D, Gaines P, Beard J. The costs of managing lower limb-threatening ischaemia. Eur J Vasc Endovasc Surg. 1996. p. 359–62.
17.
Braithwaite B, Jones L, Heather B, Birch P, Earnshaw J. Management cost of acute limb ischaemia. Br J Surg. 1996. p. 1390–3.
18.
Lurie F, Vaidya V, Comerota A. Clinical outcomes and cost-effectiveness of initial treatment strategies for nonembolic acute limb ischemia in real-life clinical settings. J Vasc Surg. 2015. p. 138–46.
19.
Vaidya V, Gangan N, Comerota A, Lurie F. Costeffectiveness analysis of initial treatment strategies for nonembolic acute limb ischemia using real-word data. Ann Vasc Surg. 2017. p. 276–83.

Citation

Authors retain copyright. This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.